Jefferies Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Jefferies Group’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-24,200	Closed	-$1.44M	–	2153
2021 Q3	$1.44M	Buy	+24,200	New	+$1.43M	0.01%	862
2019 Q2	–	Sell	-75,000	Closed	-$3.36M	–	2994
2019 Q1	$3.36M	Buy	+75,000	New	+$3.44M	0.03%	618
2018 Q3	–	Sell	-12,000	Closed	-$523K	–	2856
2018 Q2	$523K	Buy	+12,000	New	+$516K	﹤0.01%	1566
2013 Q4	–	Sell	-27,180	Closed	-$1.43M	–	2297
2013 Q3	$1.43M	Buy	27,180 +3,300	+14%	+$222K	0.01%	749
2013 Q2	$1.84M	Buy	+23,880	New	+$1.95M	0.02%	544

Jefferies Group's ARNA Position: Q1 2022 in Review

Jefferies Group sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 121,719 shares — an estimated $11.3M sold.

Jefferies Group first reported a position in ARNA in Q2 2013 and held it in 5 quarters. The position peaked at $11.3M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Jefferies Group reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Jefferies Group sold 121,719 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $11.3M.
Jefferies Group first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 5 quarters.
Jefferies Group's Arena Pharmaceuticals Inc position peaked at $11.3M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Jefferies Group's 13F filing for Q1 2022, filed 16 May 2022.